Designed and created by Guideline Central in participation with the Centers for Disease Control and Prevention
Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus
Patient Guideline Summary
Publication Date: July 1, 2022
Last Updated: March 3, 2023
Objective
Objective
This patient summary means to discuss key recommendations from the Centers for Disease Control and Prevention for the testing of transplant candidates aged <12 years for infection with HIV, hepatitis B virus, and hepatitis C virus.
Overview
Overview
Patients under the age of 12 years who are being considered for a solid organ transplant are fragile. Removing the volume of blood needed to test for these three viruses poses a greater risk to the patient than the likelihood that the patient has acquired any of those infections between the newborn period and their current age. Therefore, testing at birth is sufficient; the patient is exempt from repeat testing.
Diagnosis
Diagnosis
- Transplant candidates who are under 12 years of age at the time of transplantation and who have received postnatal infectious disease testing are exempt from pretransplant HIV, HBV, and HCV testing during hospital admission for transplantation.
Abbreviations
- HBV: Hepatitis B Virus
- HCV: Hepatitis C Virus
- HIV: Human Immunodeficiency Virus
Source Citation
Free RJ, Levi ME, Bowman JS, Bixler D, Brooks JT, Buchacz K, Moorman A, Berger J, Basavaraju SV. Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2. PMID: 35771714.
Disclaimer
The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.